摘要
目的研究步长稳心颗粒对心律失常的疗效及安全性。方法将84例心律失常患者随机分为治疗组和对照组；治疗组患者给予步长稳心颗粒1包（9g），3次／d，口服，对照组常规服用抗心律失常西药；治疗4周后，观察临床疗效及24holter动态心电图的变化，以评估其安全性。结果心电图改善比较，治疗组总有效率（90．47％）明显高于对照组（71．43％）；临床症状改善比较，治疗组总有效率（92．86％）明显高于对照组（66．67％）；两组比较差异具有统计学意义（P〈0．05）；稳心颗粒无明显的副作用。结论步长稳心颗粒治疗心律失常与对照组比较疗效显著，使用简单安全。
Objective To study the anti-arrhythmia effect and safety of wenxinkeli for the patients with cardiac arrhythmia. Methods 84 patients with cardiac arrhythmia were divided into therapy group and control group at random. Therapy group took ＂Wenxinkeli＂ 9.0g, Tid, and control group took western medicine of anti-arrhythmia. Results The ECG total effective rate of therapy group （90.47%） was higher than that of control group （71.43%）,and the clinical total effective rate of therapy group （92.86%）was higher than that of control group （66.67%）.And there was no significant side effect in wenxinkeli. Conclusion As other drug for cardiac arrhythmia, Wenxinkeli could improve the therapeutic effect, which should be asimple, safe and effective method.
出处
《国际医药卫生导报》
2008年第8期85-87,共3页
International Medicine and Health Guidance News
